For instance, through secretion of IL-6, CAFs derived from human hepatocellular carcinoma are able to upregulate the activation of the STAT3 signalling pathway in DCs, which in turn, induces a regulatory DC phenotype which is unable to prime and activate T cells [79]. This evidence concerns the gene IL6 and hepatocellular carcinoma.